Multi-site, Randomized, Opened and Controlled Comparison Study on the Effectiveness and Safety of Solifenacin Succinate Tablets and Solifenacin Succinate Tablets + Estrogen for Overactive Bladder in the Post-menopausal Women
Latest Information Update: 14 Jan 2020
At a glance
- Drugs Promestriene (Primary) ; Solifenacin (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 23 Nov 2013 New source identified and integrated (Chinese Clinical Trial Register; ChiCTR-TRC13003862).
- 25 Apr 2013 New trial record